Clinical Pharmacological study of Tofogliflozin (CSG452) in Patients with Type 2 Diabetes -Evaluation of influence by degree of kidney function -
Latest Information Update: 17 Dec 2019
At a glance
- Drugs Tofogliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- Sponsors Chugai Pharmaceutical
- 06 Jun 2016 New trial record